Skip to main content
. 2019 Aug 23;40(11):1373–1385. doi: 10.1038/s41401-019-0287-8

Fig. 4.

Fig. 4

Illustration of the esterase-responsive charge‐reversal polymer (ERP) and its lipid‐coated esterase-responsive polyplexes with TRAIL plasmid for cancer gene therapy. a The ERP is a PEI whose amines are quaternized with propionic 4‐acetoxybenzyl ester. Hydrolysis of the phenolic acetate triggers the elimination of p-hydroxymethylphenol and consequent conversion of the cationic polymer into a zwitterionic form. b ERP condenses plasmid DNA into the polyplexes, which are easily coated with DC-Chol/DOPE lipids to form lipidic esterase‐responsive polyplexes (LERPs). After i.p. injection into nude mice bearing HeLa cell-derived tumors, tumor cells internalize LERPs into the cytosol, which is rich in esterases. The LERPs disassemble and release the polyplexes to allow the esterases to trigger the charge reversal of the ERP and thus plasmid release. These free plasmids enter the nucleus for effective gene expression, inducing apoptosis when delivering the TRAIL gene. In tumor fibroblasts, the low esterase level cannot efficiently induce the charge reversal process, and the TRAIL plasmids will not be expressed, preventing WNT16B production. Reprinted with permission from [56]